CINECA IRIS Institutional Research Information System

CALVO, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.988
EU - Europa 11.367
AS - Asia 5.882
SA - Sud America 342
OC - Oceania 208
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 17
Totale 32.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.587
IT - Italia 3.440
CN - Cina 2.588
IE - Irlanda 1.241
SG - Singapore 1.227
DE - Germania 1.165
SE - Svezia 854
FR - Francia 845
GB - Regno Unito 705
FI - Finlandia 687
AT - Austria 492
KR - Corea 486
JP - Giappone 449
UA - Ucraina 381
CA - Canada 347
ES - Italia 305
NL - Olanda 303
VN - Vietnam 267
IN - India 248
PL - Polonia 205
BR - Brasile 203
AU - Australia 188
BE - Belgio 151
TW - Taiwan 109
HK - Hong Kong 102
ID - Indonesia 101
GR - Grecia 93
PT - Portogallo 91
CH - Svizzera 82
TR - Turchia 79
UZ - Uzbekistan 61
IL - Israele 60
DK - Danimarca 55
RU - Federazione Russa 51
CO - Colombia 47
AR - Argentina 45
MX - Messico 42
HU - Ungheria 38
RO - Romania 37
CZ - Repubblica Ceca 28
NO - Norvegia 25
CL - Cile 24
BG - Bulgaria 22
IR - Iran 21
NZ - Nuova Zelanda 20
PH - Filippine 18
EU - Europa 17
SN - Senegal 13
SI - Slovenia 11
TH - Thailandia 11
TN - Tunisia 11
UY - Uruguay 10
BY - Bielorussia 9
EG - Egitto 9
HR - Croazia 9
RS - Serbia 8
KZ - Kazakistan 7
MY - Malesia 7
PE - Perù 7
BA - Bosnia-Erzegovina 6
ZA - Sudafrica 6
CI - Costa d'Avorio 5
IS - Islanda 5
LU - Lussemburgo 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IQ - Iraq 4
LK - Sri Lanka 4
MU - Mauritius 4
NP - Nepal 4
PS - Palestinian Territory 4
CR - Costa Rica 3
CY - Cipro 3
LT - Lituania 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
SA - Arabia Saudita 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BD - Bangladesh 2
DO - Repubblica Dominicana 2
LB - Libano 2
MT - Malta 2
OM - Oman 2
PR - Porto Rico 2
TL - Timor Orientale 2
BF - Burkina Faso 1
BO - Bolivia 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
QA - Qatar 1
Totale 32.858
Salva come PNG Salva come JPEG
Città #
Chandler 1.718
Beijing 1.245
Dublin 1.198
Singapore 1.000
Santa Clara 945
Houston 772
Ashburn 747
Torino 668
Fairfield 627
Vienna 451
Ann Arbor 430
Villeurbanne 412
Jacksonville 387
Wilmington 361
Princeton 349
Redwood City 341
Medford 339
Woodbridge 331
Seattle 302
Turin 301
Columbus 300
Nyköping 299
Milan 247
Cambridge 240
Dearborn 222
Fremont 194
Warsaw 181
Dong Ket 169
Pisa 147
Boston 142
Lappeenranta 141
Rome 128
Guangzhou 123
Tokyo 113
New York 105
Toronto 105
Paris 96
Helsinki 94
Jakarta 93
Boardman 91
Chengdu 91
London 87
Munich 87
Nanjing 85
Shanghai 80
Brussels 72
Taipei 70
Chicago 66
Hangzhou 60
Washington 58
San Diego 57
Los Angeles 53
Hefei 49
Ottawa 47
Norwalk 45
Sydney 45
Hong Kong 43
Mumbai 42
Utrecht 42
Berlin 40
San Francisco 40
Wuhan 39
Budapest 35
Nürnberg 34
Padova 34
Athens 32
Bologna 32
Lisbon 31
Seoul 31
Detroit 30
Phoenix 30
Zhengzhou 30
Falls Church 29
Florence 29
Buenos Aires 28
Genoa 28
Mountain View 28
Shenyang 28
Kunming 27
Palermo 27
Philadelphia 27
São Paulo 27
Changsha 26
Oxford 26
Madrid 25
Hebei 24
Melbourne 24
Silver Spring 24
Valencia 24
Montreal 23
Amsterdam 22
Atlanta 22
Fuzhou 22
Istanbul 22
Nuremberg 22
Barcelona 21
Cervignano Del Friuli 21
Pittsburgh 21
Serra 21
Cagliari 20
Totale 18.459
Salva come PNG Salva come JPEG
Nome #
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model 3.265
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study 1.522
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 630
A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? 525
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson’s disease complicated by psychosis or dementia in a Sardinian population 399
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 394
The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis 340
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 331
Acoustic reflex patterns in amyotrophic lateral sclerosis 307
Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis 292
Influence of frontotemporal dementia in ALS patients and caregivers quality of life and depression 287
Validation of the Italian version of self-administered ALSFRS-R scale 278
Validation of the revised classification of cognitive and behavioural impairment in ALS 271
Curable or treatable? The implications of different definitions of illness when treating patients affected by Amyotrophic Lateral Sclerosis 246
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 240
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease 238
Amyotrophic Lateral Sclerosis Incidence and Previous Prescriptions of Drugs for the Nervous System 228
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 227
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 223
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 220
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040 218
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 217
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo 205
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 200
18 F-FDG-PET correlates of cognitive impairment in ALS 199
Factors predicting survival in ALS: a multicenter Italian study 198
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 196
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 189
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis 184
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 180
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 175
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 175
Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD 168
A longitudinal study on quality of life and depression in ALS patient-caregiver couples 165
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 161
La continuità assistenziale: miraggio o possibilità? 161
The multistep hypothesis of ALS revisited: The role of genetic mutations 161
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 160
NOX2 in the hSOD1G93A Transgenic Swine: a preliminary overview 158
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten 157
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 153
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study 150
ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons 150
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 148
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 148
Diffusion Tensor and Voxel Based Morphometry study in patients with amyotrophic lateral sclerosis 146
Large Proportion of Amyotrophic Lateral Sclerosis Cases in Sardinia Due to a Single Founder Mutation of the TARDBP Gene 144
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 143
Influence of cigarette smoking on ALS outcome: A population-based study 141
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 140
A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. 139
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 132
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 130
Expression of NOX2 protein in neutrophils of patients with ALS 128
A Distinct MR Imaging Phenotype in Amyotrophic Lateral Sclerosis: Correlation between T1 Magnetization Transfer Contrast Hyperintensity along the Corticospinal Tract and Diffusion Tensor Imaging Analysis. 128
Increased risk of ALS for frontline workers 125
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 124
Increased cytoplasmic mislocalization of TAR DNA binding protein 43 (TDP-43) in circulating lymphomonocytes of ALS patients recapitulates the major dysfunction featuring motor neurons in the disease. 123
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 122
Endogenous Cognitive Tasks for Brain-Computer Interface: A Mini-Review and a New Proposal 122
Cognitive impairment across ALS clinical stages in a population-based cohort 120
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 117
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 116
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 114
NADPH Oxidases (NOX) Enzymes Induced Oxidative Stress in CIDP Patients 113
Studio longitudinale sulla qualità di vita in pazienti affetti da SLA arruolati e non arruali in clinical trial 111
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 109
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis 109
A 10-year epidemiological prospective study of ALS in Piemonte and Valle d'Aosta, italy 108
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 107
HFE p.H63D polymorphism does not influence ALS phenotype and survival 106
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis 105
ALS patients and caregivers communication preferences and information seeking behaviour 104
Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations 103
Disfagia in Neurologia 103
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 103
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 101
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 101
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 98
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 98
Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma 98
Lower serum lipid levels are related to respiratory impairment in patient with ALS 97
Progranulin plasma levels in relation to the expected TDP-43 pathology. 97
Extensive genetics of ALS: A population-based study in Italy 97
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 97
The transcription factor Nurr1 is up-regulated in Amyotrophic Lateral Sclerosis patients and SOD1-G93A mice 97
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 97
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 96
NADPH oxidases (NOX) enzymes induced oxidative stress in CIDP patients 96
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 96
The diagnosis of FTD-ALS: a longitudinal study in a specialized dementia unit 95
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population 95
Progranulin plasma levels in patients with and without TDP-43 pathology. 95
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 95
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 95
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 94
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities 93
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 93
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 92
Segni e sintomi inusuali o rari in Neurologia 92
Totale 20.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.864
article - articoli 0
book - libri 0
conference - conferenze 19.403
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.023 0 0 0 0 0 0 434 278 383 454 249 225
2020/20213.471 305 233 221 191 280 251 273 255 480 325 192 465
2021/20224.039 181 148 200 342 248 258 238 241 207 365 835 776
2022/20236.007 662 485 201 514 534 1.350 475 377 639 234 316 220
2023/20244.037 393 502 267 289 244 332 252 532 72 387 330 437
2024/20254.486 223 625 384 851 1.750 631 22 0 0 0 0 0
Totale 33.790